Sections
| Title | Starting Page | Number of Pages |
|---|
| 1 Table of Contents | 5 | 8 |
| 1.1 List of Tables | 9 | 2 |
| 1.2 List of Figures | 11 | 2 |
| 2 Introduction | 13 | 1 |
| 2.1 GBI Research Guidance | 13 | 1 |
| 3 Global Cardiovascular Devices : Market Characterization | 14 | 12 |
| 3.1 Global Cardiovascular Devices Market, Revenue ($bn), 2002 2009 | 14 | 1 |
| 3.2 Global Cardiovascular Devices Market, Revenue ($bn), 2009 2016 | 15 | 1 |
| 3.3 Global Cardiovascular Devices Market, Key Company Share (%), 2009 | 16 | 1 |
| 3.4 Global Cardiovascular Devices Market, Key Trends | 17 | 1 |
| 3.4.1.1 Cardiac Rhythm Management Devices Market is Under-Penetrated and Offers Huge Growth Opportunity for the Big Players | 17 | 2 |
| 3.4.1.2 Emerging Countries Hold the Key to Future Growth in the Cardiovascular Device Market | 19 | 1 |
| 3.4.1.3 Consolidation Taking Place in Electrophysiology and Peripheral Vascular Devices Market through Focused Mergers and Acquisitions by Big Players | 20 | 2 |
| 3.5 Global Cardiovascular Devices, Market Dynamics | 22 | 1 |
| 3.5.1 Market Drivers | 22 | 1 |
| Rising Incidence of Cardiovascular Diseases Driving the Market | 22 | 1 |
| 3.5.1.2 Population Aged above 60 is Driving the Growth of Overall Cardiovascular Device Market | 23 | 1 |
| 3.5.1.3 Increasing Adoption of Minimally Invasive Techniques Boosting Cardiovascular Procedure Volumes | 24 | 1 |
| 3.5.1.4 China s New Healthcare Reform Policy is Expected to Propel the Growth of the Cardiovascular Devices Market | 24 | 1 |
| 3.5.2 Market Restraints | 25 | 1 |
| 3.5.2.1 Reimbursement Cuts and High Cost of Devices Impeding the Growth of the Cardiovascular Device Market | 25 | 1 |
| 3.5.2.2 High Percentage of Uninsured Population in Emerging Countries Resulting in Reduced Uptake of Cardiovascular Devices | 25 | 1 |
| 4 Global Cardiovascular Devices Market: Category Analysis and Forecasts | 26 | 46 |
| 4.1 Cardiac Rhythm Management Devices | 26 | 1 |
| 4.1.1 Cardiac Rhythm Management Devices Market, Global, Revenue ($bn), 2002 2009 | 27 | 1 |
| 4.1.2 Cardiac Rhythm Management Devices Market, Global, Revenue ($bn), 2009 2016 | 28 | 1 |
| Cardiac Rhythm Management Devices Market, Global, Key Company Share (%), 2009 | 29 | 1 |
| 4.1.4 Cardiac Rhythm Management Devices: Market Dynamics | 30 | 1 |
| 4.1.5 Market Drivers | 30 | 1 |
| 4.1.5.1 Advanced Technological Innovations in Cardiac Rhythm Management Bolstering the Market Ahead | 30 | 1 |
| 4.1.5.2 Favorable Outcomes of Significant Clinical Trials are Expected to Help the ICD Market Grow through Expansion of Device Indication | 30 | 1 |
| 4.1.5.3 New Technological Innovations Have Led to Increases in Average Selling Prices | 31 | 1 |
| 4.1.5.4 Remote Patient Monitoring a Required Feature in Cardiac Rhythm Management | 31 | 1 |
| 4.1.5.5 Robust Pipeline Products from Several Key Players Would Augment Future Growth in Revenues | 32 | 1 |
| 4.1.6 Market Restraints | 33 | 1 |
| 4.1.6.1 Low Penetration in Emerging Markets Continues to Negatively Affect Overall Revenues | 33 | 1 |
| 4.1.6.2 High Cost of Device Restraining Uptakes | 33 | 1 |
| 4.2 Interventional Cardiology | 34 | 1 |
| 4.2.1 Interventional Cardiology Market, Global, Revenue ($bn), 2002 2009 | 35 | 1 |
| 4.2.2 Interventional Cardiology Market, Global, Revenue ($bn), 2009 2016 | 36 | 1 |
| 4.2.3 Interventional Cardiology Market, Global, Key Company Share (%), 2009 | 37 | 1 |
| 4.2.4 Interventional Cardiology: Market Dynamics | 38 | 1 |
| 4.2.5 Market Drivers | 38 | 1 |
| 4.2.5.1 Greater Surgeon Adoption Rate for Minimally Invasive Procedures Responsible for Surge in Interventional Cardiology Devices Market | 38 | 1 |
| Robust Pipeline in Interventional Cardiology Devices is expected to Bring New Products and Increase Competition in the Global Market | 38 | 1 |
| 4.2.5.3 Drug Eluting Stents to Continue Driving the Market Growth due to High Surgeon Adoption Rates | 39 | 1 |
| 4.2.5.4 Technological Advancements Such as Bioabsorbable Stents Expected to Drive the Global Coronary Stent Market | 39 | 1 |
| 4.2.5.5 Increased Catheterization Procedures Leading to Overall Market Growth | 39 | 1 |
| 4.2.6 Market Restraints | 40 | 1 |
| 4.2.6.1 Negative Clinical Outcomes and Complications of In-Stent Re-Stenosis have Affected the Growth of the Market | 40 | 1 |
| 4.2.6.2 Re-stenosis is Acting as a Deterrent to Increased Uptake of Coronary Stents Volumes | 40 | 1 |
| 4.2.6.3 Alternative Treatment Options and Preference of Pharmacological Therapies is Minimizing the Need for PCI Procedures | 40 | 1 |
| 4.3 Peripheral Vascular Devices | 41 | 1 |
| 4.3.1 Peripheral Vascular Devices Market, Global, Revenue ($m), 2002 2009 | 42 | 1 |
| 4.3.2 Peripheral Vascular Devices Market, Global, Revenue ($m), 2009 2016 | 43 | 1 |
| 4.3.3 Peripheral Vascular Devices Market, Global, Key Company Share (%), 2009 | 44 | 1 |
| 4.3.4 Peripheral Vascular Devices: Market Drivers | 45 | 1 |
| 4.3.4.1 Increasing Detection and Treatment of Abdominal Aortic Aneurysms Contributing to the Growth of Aortic Stent Graft Market | 45 | 1 |
| 4.3.4.2 New Products and Techniques that Improve Clinical Outcomes to Boost Adoption Rates of Various Peripheral Vascular Devices | 45 | 1 |
| 4.3.4.3 Increased Adoption Rate for Endovascular Aortic Repair To Drive the Procedure Volumes in Aortic Aneurysm Repair | 45 | 1 |
| 4.3.4.4 Transition from Surgical Clipping to Endovascular Coiling is Leading to Increased Growth in Embolic Protection Devices Market | 46 | 1 |
| 4.3.5 Market Restraints | 46 | 1 |
| 4.3.5.1 Requirement of Highly Skilled Surgeons due to the Complexities Associated with Peripheral Vascular Procedures is Limiting the Growth of Procedure Volumes. | 46 | 1 |
| 4.3.5.2 Lack of Adequate Reimbursement in Emerging Countries and Regulatory Policies in Japan are Deterring the Growth of Peripheral Vascular Devices Market. | 46 | 1 |
| 4.4 Cardiovascular Prosthetic Devices | 47 | 1 |
| 4.4.1 Cardiovascular Prosthetic Devices Market, Global, Revenue ($m), 2002 2009 | 48 | 1 |
| 4.4.2 Cardiovascular Prosthetic Devices Market, Global, Revenue ($m), 2009 2016 | 49 | 1 |
| 4.4.3 Cardiovascular Prosthetic Devices Market, Global, Key Company Share (%), 2009 | 50 | 1 |
| 4.4.4 Cardiovascular Prosthetic Devices: Market Drivers | 51 | 1 |
| 4.4.4.1 Innovative Products with New Technologies to Drive Adoption of Tissue Heart Valves | 51 | 1 |
| 4.4.4.2 Encouraging Clinical Trial Outcomes of Transcatheter Heart Valve Technology are Expected to Result in Increased Procedure Volumes in High Risk Patients | 51 | 1 |
| 4.4.4.3 New Product Approvals and Technology Changes in Cardiac Assist Devices Expected to Bolster Future Adoption Rates | 52 | 1 |
| 4.4.5 Market Restraints | 52 | 1 |
| 4.4.5.1 Lack of Robust Clinical Data will Increase Diversity of Opinion Regarding Valvular Disease Management | 52 | 1 |
| 4.4.5.2 Lack of Clarity on Reimbursement of Transcatheter Heart Valves (THV) May Deter Higher Uptake of the Devices | 52 | 1 |
| 4.5 Cardiovascular Surgery Devices | 53 | 1 |
| 4.5.1 Cardiovascular Surgery Devices Market, Global, Revenue ($m), 2002 2009 | 54 | 1 |
| 4.5.2 Cardiovascular Surgery Devices Market, Global, Revenue ($m), 2009 2016 | 55 | 1 |
| 4.5.3 Cardiovascular Surgery Devices Market, Global, Key Company Share (%), 2009 | 56 | 1 |
| 4.5.4 Cardiovascular Surgery Devices: Market Drivers | 57 | 1 |
| 4.5.4.1 New Technological Advances and Techniques in Cardiovascular Surgery Expected to Drive Future Adoption Rates | 57 | 1 |
| 4.5.4.2 On Pump Surgeries to Boost Market Revenues in the Emerging Countries | 58 | 1 |
| 4.5.4.3 CABG as the Only Choice in Case of Failed PCI Procedures and for Post Infarction Patients to Sustain the Market Growth | 58 | 1 |
| 4.5.5 Market Restraints | 58 | 1 |
| 4.5.5.1 Advances in Catheter Based Interventions, Increased Patient and Surgeon Preference for PCI have Stunted the Cardiovascular Surgery Devices Market Growth | 58 | 1 |
| 4.5.5.2 Increased Interest in the Interventional Cardiology Sphere by Major Companies and Investors Shifting the Focus away from Cardiovascular Surgery Devices | 58 | 1 |
| 4.5.5.3 Cardiovascular Surgery Requires a High Degree of Skill, Which is Leading to Low Surgeon Preference | 59 | 1 |
| 4.6 Electrophysiology | 59 | 1 |
| 4.6.1 Electrophysiology Market, Global, Revenue ($m), 2002 2009 | 60 | 1 |
| 4.6.2 Electrophysiology Market, Global, Revenue ($m), 2009 2016 | 61 | 1 |
| 4.6.3 Electrophysiology Market, Global, Key Company Share (%), 2009 | 62 | 1 |
| 4.6.4 Electrophysiology: Market Drivers | 63 | 1 |
| 4.6.4.1 Increasing Applications of Electrophysiology Having a Positive Impact on the Market | 63 | 1 |
| 4.6.4.2 Growing Adoption Rates of Electrophysiology as a Treatment Modality to Drive the Market | 63 | 1 |
| 4.6.4.3 New Product Approvals and Technological Advances to Boost the Electrophysiology Market | 63 | 1 |
| 4.6.4.4 Population above the Age of 60 is Leading to Increased Patient Pool Suffering from Atrial Fibrillation | 64 | 1 |
| 4.6.5 Market Restraints | 65 | 1 |
| 4.6.5.1 Under Diagnosis and Under Penetration Only 30% of US Electrophysiologists Perform Ablation Procedures. | 65 | 1 |
| 4.6.5.2 Increased Use of Reprocessed Catheters would Negatively Affect the Overall Revenues in the US and Europe | 65 | 1 |
| 4.6.5.3 Lack of Skilled and Trained Professionals would Negatively Affect the Procedure Volumes | 65 | 1 |
| 4.6.5.4 Huge Initial Set-Up Costs for Hospitals Resulting in Inadequate Number of Electrophysiology Centers in Developing Countries | 65 | 1 |
| 4.7 Cardiovascular Monitoring and Diagnostic Devices | 66 | 1 |
| 4.7.1 Cardiovascular Monitoring and Diagnostic Devices Market, Global, Revenue ($m), 2002 2009 | 67 | 1 |
| 4.7.2 Cardiovascular Monitoring and Diagnostic Devices Market, Global, Revenue ($m), 2009 2016 | 68 | 1 |
| 4.7.3 Cardiovascular Monitoring and Diagnostic Devices Market, Global, Key Company Share (%), 2009 | 69 | 1 |
| 4.8 Cardiovascular Monitoring and Diagnostic Devices: Market Dynamics | 70 | 1 |
| 4.8.1 Market Drivers | 70 | 1 |
| 4.8.1.1 Advancements in Technology Boost Demand within the Cardiovascular Monitoring and Diagnostic Devices Market | 70 | 1 |
| 4.8.1.2 Rising Number of Physician Offices Leading to Additional Sale of ECG Monitoring Devices | 70 | 1 |
| 4.8.1.3 Rising Incidence of Cardiovascular Diseases Resulting in Significant Growth of Diagnostic and Monitoring Tests | 70 | 1 |
| 4.8.1.4 Growing Usage of Diagnostic and Monitoring Devices for Cardiovascular Disease Testing as Emphasis on Preventive Care Increases | 70 | 1 |
| 4.8.2 Market Restraints | 71 | 1 |
| 4.8.2.1 Maturity of the Market Limits Growth and Innovation Capacities for the Future | 71 | 1 |
| 4.8.2.2 Strategies to Reduce Infrastructure Expenditure by Hospitals has led to Decrease in Value of Diagnostic and Monitoring Devices Market | 71 | 1 |
| 5 Global Cardiovascular Devices Market: Country Analysis and Forecasts | 72 | 27 |
| Cardiovascular Devices Market: Cross-Country Analysis | 72 | 1 |
| 5.2 Historic (2002 2009) and Forecast (2009-2016) Revenue, By Country | 73 | 1 |
| 5.2.1 Cardiovascular Devices Market, US, Revenue ($bn), 2002 2009 | 73 | 1 |
| 5.2.2 Cardiovascular Devices Market, US, Revenue ($bn), 2009 2016 | 74 | 1 |
| 5.2.3 Cardiovascular Devices Market, Canada, Revenue ($m), 2002 2009 | 75 | 1 |
| 5.2.4 Cardiovascular Devices Market, Canada, Revenue ($m), 2009 2016 | 76 | 1 |
| 5.2.5 Cardiovascular Devices Market, UK, Revenue ($m), 2002 2009 | 77 | 1 |
| 5.2.6 Cardiovascular Devices Market, UK, Revenue ($m), 2009 2016 | 78 | 1 |
| 5.2.7 Cardiovascular Devices Market, Germany, Revenue ($m), 2002 2009 | 79 | 1 |
| 5.2.8 Cardiovascular Devices Market, Germany, Revenue ($m), 2009 2016 | 80 | 2 |
| 5.2.9 Cardiovascular Devices Market, France, Revenue ($m), 2002 2009 | 82 | 1 |
| 5.2.10 Cardiovascular Devices Market, France, Revenue ($m), 2009 2016 | 83 | 1 |
| 5.2.11 Cardiovascular Devices Market, Italy, Revenue ($m), 2002 2009 | 84 | 1 |
| 5.2.12 Cardiovascular Devices Market, Italy, Revenue ($m), 2009 2016 | 85 | 2 |
| 5.2.13 Cardiovascular Devices Market, Spain, Revenue ($m), 2002 2009 | 87 | 1 |
| 5.2.14 Cardiovascular Devices Market, Spain, Revenue ($m), 2009 2016 | 88 | 1 |
| 5.2.15 Cardiovascular Devices Market, Brazil, Revenue ($m), 2002 2009 | 89 | 1 |
| 5.2.16 Cardiovascular Devices Market, Brazil, Revenue ($m), 2009 2016 | 90 | 1 |
| 5.2.17 Cardiovascular Devices Market, Japan, Revenue ($m), 2002 2009 | 91 | 1 |
| 5.2.18 Cardiovascular Devices Market, Japan, Revenue ($m), 2009 2016 | 92 | 1 |
| 5.2.19 Cardiovascular Devices Market, China, Revenue ($m), 2002 2009 | 93 | 1 |
| 5.2.20 Cardiovascular Devices Market, China, Revenue ($m), 2009 2016 | 94 | 1 |
| 5.2.21 Cardiovascular Devices Market, India, Revenue ($m), 2002 2009 | 95 | 1 |
| 5.2.22 Cardiovascular Devices Market, India, Revenue ($m), 2009 2016 | 96 | 1 |
| 5.2.23 Cardiovascular Devices Market, Australia, Revenue ($m), 2002 2009 | 97 | 1 |
| 5.2.24 Cardiovascular Devices Market, Australia, Revenue ($m), 2009 2016 | 98 | 1 |
| 6 Global Cardiovascular Devices Market: Competitive Assessment | 99 | 8 |
| 6.1 Medtronic, Inc | 100 | 1 |
| 6.1.1 Business Overview | 100 | 1 |
| 6.1.2 Key Marketed Products | 100 | 1 |
| 6.2 Boston Scientific Corporation | 101 | 1 |
| 6.2.1 Business Overview | 101 | 1 |
| 6.2.2 Key Marketed Products | 101 | 1 |
| 6.3 St. Jude Medical, Inc. | 102 | 1 |
| 6.3.1 Business Overview | 102 | 1 |
| 6.3.2 Key Marketed Products | 102 | 1 |
| 6.4 Abbott | 103 | 1 |
| 6.4.1 Business Overview | 103 | 1 |
| 6.4.2 Key Marketed Products | 103 | 1 |
| 6.5 Cordis | 103 | 1 |
| 6.5.1 Business Overview | 103 | 1 |
| 6.5.2 Key Marketed Products | 103 | 1 |
| 6.6 Terumo Corporation | 104 | 1 |
| 6.6.1 Business Overview | 104 | 1 |
| 6.6.2 Key Marketed Products | 104 | 1 |
| 6.7 Sorin Group | 104 | 1 |
| 6.7.1 Business Overview | 104 | 1 |
| 6.7.2 Key Marketed Products | 104 | 1 |
| 6.8 Edwards Lifesciences Corporation | 104 | 1 |
| 6.8.1 Business Overview | 104 | 1 |
| 6.8.2 Key Marketed Products | 104 | 1 |
| 6.9 C.R. Bard, Inc. | 105 | 1 |
| 6.9.1 Business Overview | 105 | 1 |
| 6.9.2 Key Marketed Products | 105 | 1 |
| 6.10 Biosense Webster, Inc. | 105 | 1 |
| 6.10.1 Business Overview | 105 | 1 |
| 6.10.2 Key Marketed Products | 105 | 1 |
| 6.11 BIOTRONIK SE &Co. KG | 106 | 1 |
| 6.11.1 Business Overview | 106 | 1 |
| 6.11.2 Key Marketed Products | 106 | 1 |
| 7 Global Cardiovascular Devices Market: Product Pipeline Analysis | 107 | 55 |
| 7.1 Cardiovascular Rhythm Management Devices | 107 | 1 |
| 7.2 Cardiac Rhythm Management Devices: List of Pipeline Products | 108 | 3 |
| 7.3 Profiles of Key Pipeline Products: Cardiac Rhythm Management | 111 | 1 |
| 7.3.1 Pacemakers | 111 | 1 |
| 7.3.1.1 Advisa DR | 111 | 1 |
| 7.3.1.2 Reply MRI | 111 | 1 |
| 7.3.1.3 Accent MRI | 111 | 1 |
| 7.3.1.4 Ensure MRI | 112 | 1 |
| 7.3.2 Implantable Cardioverter Defibrillator | 112 | 1 |
| 7.3.2.1 Fortify ST | 112 | 1 |
| 7.3.2.2 Paradym DR | 112 | 1 |
| 7.3.2.3 Protecta XT VR | 112 | 1 |
| 7.3.3 Cardiac Resynchronization Therapy | 113 | 1 |
| 7.3.3.1 Promote Q | 113 | 1 |
| 7.3.3.2 Paradym RF | 113 | 1 |
| 7.3.3.3 Protecta CRT-D | 113 | 1 |
| 7.4 Cardiac Monitoring and Diagnostic Devices | 114 | 1 |
| 7.5 Cardiovascular Diagnostic and Monitoring Devices: List of Pipeline Products | 115 | 2 |
| 7.6 Profiles of Key Pipeline Products: Cardiovascular Monitoring and Diagnostic Devices | 117 | 1 |
| 7.6.1 ECG Monitoring Equipment | 117 | 1 |
| 7.6.1.1 AngelMed Guardian System | 117 | 1 |
| 7.6.1.2 dBG 300 | 118 | 1 |
| 7.6.2 Event Monitoring System | 118 | 1 |
| 7.6.2.1 SupraQ | 118 | 1 |
| 7.6.3 ECG Stress Testing Systems | 118 | 1 |
| 7.6.3.1 CVInsight | 118 | 1 |
| 7.6.4 Holter Monitoring Systems | 118 | 1 |
| 7.6.4.1 Fidelity 350 Holter Monitor | 118 | 1 |
| 7.6.4.2 Vectraplex PDA | 118 | 1 |
| 7.7 Cardiovascular Surgery | 119 | 1 |
| 7.8 Cardiovascular Surgery: List of Pipeline Products | 120 | 1 |
| 7.9 Profiles of Key Pipeline Products: Cardiovascular Surgery | 121 | 1 |
| 7.9.1 Cardiopulmonary Bypass Equipment | 121 | 1 |
| 7.9.1.1 C5 HLM | 121 | 1 |
| 7.9.2 Oxygenators | 121 | 1 |
| 7.9.2.1 New Oxy Apex HP oxygenator | 121 | 1 |
| 7.9.3 Perfusion Disposables | 121 | 1 |
| 7.9.3.1 DownStream AO Cartridge | 121 | 1 |
| 7.9.4 Cardiac Ablation Devices | 122 | 1 |
| 7.9.4.1 ClariVein-Vascular Ablation | 122 | 1 |
| 7.10 Interventional Cardiology Devices | 122 | 1 |
| 7.11 Interventional Cardiology: List of Pipeline Products | 123 | 10 |
| 7.12 Profiles of Key Pipeline Products: Interventional Cardiology Devices | 133 | 1 |
| 7.12.1 Coronary Stents | 133 | 1 |
| 7.12.1.1 Combo Bio-engineered Sirolimus Eluting Stent | 133 | 1 |
| 7.12.1.2 Coroflex DEBlue | 133 | 1 |
| 7.12.1.3 XIENCE NANO | 133 | 1 |
| 7.12.1.4 JST Drug-Eluting Stent | 134 | 1 |
| 7.12.1.5 PROTEX Coronary Stent System | 134 | 1 |
| 7.12.1.6 Genius TAXCOR I | 134 | 1 |
| 7.12.2 Cardiac Catheters | 135 | 1 |
| 7.12.2.1 Angioslide eXtra | 135 | 1 |
| 7.12.2.2 Funnel Catheter | 135 | 1 |
| 7.12.3 PTCA Balloons | 135 | 1 |
| 7.12.3.1 Zylon Zero-Fold Angioplasty balloon catheter | 135 | 1 |
| 7.12.3.2 Ostial balloon | 135 | 1 |
| 7.12.3.3 Avion Bifurcation RX2 | 135 | 1 |
| 7.12.4 Arteriotomy Closure Devices | 135 | 1 |
| 7.12.4.1 CloSys Hemostasis Device | 135 | 1 |
| 7.12.4.2 EpiClose Plus | 136 | 1 |
| 7.12.5 Coronary Guidewires | 136 | 1 |
| 7.12.5.1 Variable Control Guidewire System | 136 | 1 |
| 7.12.5.2 Safe-Cross RF CTO System-next generation | 136 | 1 |
| 7.13 Cardiovascular Prosthetic Devices | 137 | 1 |
| 7.14 Cardiovascular Prosthetic Devices: List of Pipeline Products | 138 | 4 |
| 7.15 Profiles of Key Pipeline Products: Cardiovascular Prosthetic Devices | 142 | 1 |
| 7.15.1 Prosthetic Heart Valves | 142 | 1 |
| 7.15.1.1 Polymer Heart Valve | 142 | 1 |
| 7.15.1.2 Ventor Embracer | 142 | 1 |
| 7.15.1.3 CoreValve ReValving System | 142 | 1 |
| 7.15.1.4 Edwards SAPIEN Transcatheter Heart Valve | 143 | 1 |
| 7.15.2 Cardiac Valve Repair | 143 | 1 |
| 7.15.2.1 MitraClip Device | 143 | 1 |
| 7.15.2.2 BACE (Basal Annuloplasty of the Cardia Externally) | 143 | 1 |